NCT01491802
- Conditions
- Behavior, COPD, Chronic Disease, +12 more
- Locations
-
- Respiratory Investigation Unit at Kingston General Hospital Kingston, Ontario, Canada
Clinical trial condition
Pulmonary Disease, Chronic Obstructive
Explore clinical trials studying Pulmonary Disease, Chronic Obstructive. Study availability and eligibility vary by location and protocol.
4,016 public trials
394 recruiting studies
Pulmonary Disease, Chronic Obstructive trial results
NCT01602237
- Conditions
- Chronic Disease, Chronic Obstructive Lung Disease, Disease Attributes, +11 more
- Locations
-
- Dept. of Occupational Medicine, Haukeland University Hospital Bergen, Norway
NCT01527773
- Conditions
- Cardiovascular Diseases, Chronic Disease, Chronic Obstructive Pulmonary Disease, +7 more
- Locations
-
- University Hospital Zurich, Pneumology Zurich, Canton of Zurich, Switzerland
NCT00694902
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
- GSK Investigational Site Berlin, Germany
NCT02838953
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
- Casa di Cura Villa Serena Piossasco, Italy
NCT00702910
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
- GSK Investigational Site Auchenflower, Queensland, Australia
- GSK Investigational Site Clayton, Victoria, Australia
- GSK Investigational Site Wellington, New Zealand
NCT00987740
- Conditions
- Chronic Disease, Disease Attributes, Hypercapnic Respiratory Failure, COPD, +8 more
- Locations
-
- Artemis Health Institute Gurgaon, Haryana, India
Completed
Small Intestinal Absorption in Patients With Chronic Obstructive Pulmonary Disease and Cor Pulmonale
NCT03243994
- Conditions
- Cardiovascular Diseases, Chronic Disease, Chronic Obstructive Pulmonary Disease, +16 more
- Locations
-
Not specified
NCT00615576
- Conditions
- Chronic Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, +11 more
- Locations
-
- GSK Investigational Site London, United Kingdom
Completed
A Study To Investigate The Effect Of Inhaling A Single Dose Of GW642444M In Asthmatic Patients
NCT00463697
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
- GSK Investigational Site Harrow, Middlesex, United Kingdom
- GSK Investigational Site London, United Kingdom
- GSK Investigational Site Manchester, United Kingdom